Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Guanle Medical Technology is a specialized medical device company headquartered in Beijing, China, focusing on the field of interventional cardiology. The company is primarily recognized for its development of advanced drug-coated balloon (DCB) systems used to treat coronary artery disease and other vascular obstructions. Their flagship product, the Guanle DCB, utilizes a paclitaxel coating to prevent restenosis, offering a stent-free therapeutic option for patients. Beyond coronary applications, the company is expanding its portfolio into peripheral vascular interventions and other minimally invasive surgical consumables. Guanle Medical integrates R&D, manufacturing, and commercial operations to provide high-quality solutions for the Chinese healthcare market. The company has received significant backing from prominent venture capital firms, supporting its mission to innovate within the high-end medical consumable sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Guanle Medical Technology.